Fundz

Veritas Aortic Solutions, a Costa Mesa-based medical device company, raised $12M in Seed funding, led by Cedars-Sinai Intellectual Property Company and inQB8's investors, to develop its transcatheter valved aortic root conduit.

PRIVATEJun 01, 2026

Amount Raised

$12 Million

Round Type

Seed

Costa MesaManufacturingBiotechnologyHealth CareMedicalMedical Device

Investors

In Qb8’s Existing InvestorsCedars Sinai Intellectual Property Company

Description

Veritas Aortic Solutions, a Costa Mesa, CA-based privately held medical device company, raised $12M in Seed funding. Backers included Cedars-Sinai Intellectual Property Company along with inQB8’s existing investors. The funds will support the continued development of the Veritas transcatheter valved aortic root conduit (TVARC) through first-in-human clinical use. Led by CEO J

Quick answer

Veritas Aortic Solutions raised $12 Million in a Seed round, dated June 1, 2026. Investors: In Qb8’s Existing Investors and Cedars Sinai Intellectual Property Company. Veritas Aortic Solutions is based in Costa Mesa, California, United States.

How much did Veritas Aortic Solutions raise?
Veritas Aortic Solutions raised $12 Million in a Seed round on June 1, 2026.
Who invested in Veritas Aortic Solutions?
In Qb8’s Existing Investors and Cedars Sinai Intellectual Property Company are named as investors in this round.
What does Veritas Aortic Solutions do?
Veritas Aortic Solutions is a privately held medical device company focused on improving outcomes for patients with aortic disease.
Where is Veritas Aortic Solutions based and how big is it?
Veritas Aortic Solutions is based in Costa Mesa, California, United States.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Veritas Aortic Solutions that raised within 45 days of this round, from Fundz verified event records.

  • Endo Tools Therapeutics raised $23M (Series C) on July 16, 2026.
  • Biobot Surgical raised $15M (Funding Round) on June 29, 2026.
  • IceCure Medical raised $17M on June 17, 2026.
  • Icarus Medical raised $7.2M (Series A) on June 17, 2026.
  • FesariusTherapeutics raised $20M (Series A) on June 10, 2026.
  • NVENTRIC raised $23M on June 10, 2026.

Who to call at Veritas Aortic Solutions, and when

A new round usually means Veritas Aortic Solutions is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Veritas Aortic Solutions raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Veritas Aortic Solutions, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Veritas Aortic Solutions. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Veritas Aortic Solutions

Location

Costa Mesa, California, United States

About

Veritas Aortic Solutions is a privately held medical device company focused on improving outcomes for patients with aortic disease. Their flagship technology, the Veritas transcatheter valved aortic root conduit (TVARC), is designed to restore healthy blood flow by sealing off diseased parts of the aorta. The company was founded within inQB8 Medical Technologies and operates to provide comprehensive solutions for critical heart pathologies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Veritas Aortic Solutions raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Veritas Aortic Solutions's next move

See what Strategic adds

Veritas Aortic Solutions raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.